Literature DB >> 9697995

IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity?

J R de la Vega1, J C Vilaplana, A Biro, L Hammond, G F Bottazzo, R Mirakian.   

Abstract

IL-10 is a cytokine which not only suppresses cellular immunity but also stimulates the humoral response. In certain animal models of autoimmunity, IL-10 exerts a protective effect against autodestruction. This study was to ascertain whether there could be a role for IL-10 in human autoimmune thyroid disease. Total RNA was extracted from snap-frozen thyroid blocks from surgical specimens. Five 'normal', five multinodular, six Graves and two Hashimoto thyroids (one euthyroid and one hypothyroid) were studied. Approximately 7 microg of total RNA from each gland were reverse transcribed with oligo-dT primers. Pre-plateau semiquantitative polymerase chain reaction (PCR) was performed with specific IL-10 primers. PCR products were run on a 1-5% agarose gel, blotted onto a N-hybond nylon membrane, hybridized with a specific internal probe labelled with gamma-32P-ATP and autoradiographed. Statistical analysis of densitometric values showed significantly higher IL-10 levels in the autoimmune than in the non-autoimmune glands. In situ hybridization and immunohistochemistry showed that the IL-10 message was located within the infiltrating lymphomononuclear cells. Histological analysis revealed that the autoimmune thyroids with the highest IL-10 levels were characterized by relevant degrees of B and T cell infiltration and also exhibited the greatest percentage of spontaneous HLA class II expression on thyrocytes. IL-10 and neutralizing anti-IL-10 antibodies were not able to regulate in vitro spontaneous or interferon-gamma (IFN-gamma)/phytohaemagglutinin (PHA)-induced HLA class II on thyrocytes. We conclude that in active autoimmune thyroiditis, in addition to the well documented production of Th1 cytokines, Th2-related lymphokines can be detected simultaneously. It can be envisaged that in this condition the role of IL-10 might be directed to the stimulation of B cell proliferation and antibody production rather than to the suppression of proinflammatory cytokine release.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697995      PMCID: PMC1905025          DOI: 10.1046/j.1365-2249.1998.00628.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

Authors:  S Sad; R Marcotte; T R Mosmann
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

2.  Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT.

Authors:  K Mignon-Godefroy; O Rott; M P Brazillet; J Charreire
Journal:  J Immunol       Date:  1995-06-15       Impact factor: 5.422

Review 3.  Insulin-dependent diabetes mellitus.

Authors:  R Tisch; H McDevitt
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

Review 4.  Properties and functions of interleukin-10.

Authors:  T R Mosmann
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

Review 5.  The Th1/Th2 balance in autoimmunity.

Authors:  B Charlton; K J Lafferty
Journal:  Curr Opin Immunol       Date:  1995-12       Impact factor: 7.486

6.  Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse.

Authors:  K J Pennline; E Roque-Gaffney; M Monahan
Journal:  Clin Immunol Immunopathol       Date:  1994-05

7.  High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane.

Authors:  S B Cohen; P D Katsikis; C Q Chu; H Thomssen; L M Webb; R N Maini; M Londei; M Feldmann
Journal:  Arthritis Rheum       Date:  1995-07

8.  Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

Authors:  O Rott; B Fleischer; E Cash
Journal:  Eur J Immunol       Date:  1994-06       Impact factor: 5.532

Review 9.  Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

Authors:  I André; A Gonzalez; B Wang; J Katz; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR).

Authors:  M Heuer; G Aust; S Ode-Hakim; W A Scherbaum
Journal:  Thyroid       Date:  1996-04       Impact factor: 6.568

View more
  10 in total

1.  Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease.

Authors:  C H Nielsen; L Hegedüs; K Rieneck; A C Moeller; R G Q Leslie; K Bendtzen
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity.

Authors:  Balaji B Ganesh; Palash Bhattacharya; Anupama Gopisetty; Bellur S Prabhakar
Journal:  J Interferon Cytokine Res       Date:  2011-08-08       Impact factor: 2.607

Review 3.  Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment.

Authors:  Francesca Pastore; Antonio Martocchia; Manuela Stefanelli; Pietro Prunas; Stefania Giordano; Lavinia Toussan; Antonio Devito; Paolo Falaschi
Journal:  World J Hepatol       Date:  2016-01-18

4.  Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis.

Authors:  Yujiang Fang; Gordon C Sharp; Helen Braley-Mullen
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

5.  Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.

Authors:  M Kita-Furuyama; Y Nagayama; P Pichurin; S M McLachlan; B Rapoport; K Eguchi
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

6.  Co-existence of Hashimoto's thyroiditis with familial Mediterranean fever: is there a pathophysiological association between the two diseases?

Authors:  E Gulcan; A Gulcan; M Koplay; A Alcelik; U Korkmaz
Journal:  Clin Exp Immunol       Date:  2009-02-19       Impact factor: 4.330

7.  Cell-type-specific expression of STAT transcription factors in tissue samples from patients with lymphocytic thyroiditis.

Authors:  Julia Staab; Peter J Barth; Thomas Meyer
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

8.  Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer.

Authors:  Lucas Leite Cunha; Alfio Jose Tincani; Ligia Vera Montalli da Assumpção; Fernando Augusto Soares; José Vassallo; Laura Sterian Ward
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  The interaction of oxidative stress response with cytokines in the thyrotoxic rat: is there a link?

Authors:  Balahan Makay; Ozer Makay; Cigdem Yenisey; Gokhan Icoz; Gokhan Ozgen; Erbil Unsal; Mahir Akyildiz; Enis Yetkin
Journal:  Mediators Inflamm       Date:  2009-03-30       Impact factor: 4.711

10.  Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Authors:  Matteo Martino; Giulio Rocchi; Andrea Escelsior; Michele Fornaro
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.